Document is current
Any future updates will be listed below
-
Authors
Soliman, Gamal
Elzalabany, Mahmoud S.
Hassanein, Tarek
Miller, F. DeWolfe http://orcid.org/0000-0002-5130-056X
-
Funding
Funding for this research was provided by:
Tahya Misr Egyptian National Fund (NA)
- License Information
-
More Information
Article History
Received: 20 July 2019
Accepted: 16 September 2019
First Online: 22 October 2019
Ethics approval and consent to participate
: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Luxor HCV Treatment Center ethics committee. All participants gave written informed consent in Arabic to participate in the screening program. Participants found to be positive for anti-HCV antibodies or HBsAg were contacted and scheduled for examination and treatment at the center. For analysis, only data on age, gender, and anti-HCV and HBsAg status were available and any other identifying information was removed.
: Not applicable.
: The authors declare that they have no competing interests.
